Video Shorts

1:31
Exec on Execs: Compliance Burdens
2 months ago
by
Mike Hollan

1:21
Market Movers RX: Eli Lilly Shares Drop
3 months ago
by
Nicholas Jacobus

0:54
Why Global Science Innovation is Shifting to Asia
3 months ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: Identifying the Gaps
3 months ago
by
Mike Hollan

1:22
Market Movers RX: Gilead Sciences Leads Gainers
3 months ago
by
Nicholas Jacobus

0:57
Targeted Resilience: A Smarter Tariff Response
3 months ago
by
Nicholas Jacobus(+1 more)

0:52
The 340B Drug Pricing Secret
3 months ago
by
Mike Hollan(+1 more)

2:23
Exec on Execs: Fixing What's Broken
3 months ago
by
Mike Hollan

1:32
Market Movers RX: Moderna Leads Gainers
3 months ago
by
Nicholas Jacobus

0:55
Why Multiple Databases Are Killing Your Business Efficiency
3 months ago
by
Mike Hollan(+1 more)

1:34
Exec on Execs: An Industry Facing Change
3 months ago
by
Mike Hollan

0:56
Biotech Security: A New National Defense Priority
3 months ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: China's Rise in Biotech Investment
3 months ago
by
Mike Hollan

1:13
Market Movers Rx: Iqvia Leads Gainers
3 months ago
by
Nicholas Jacobus

1:53
Execs on Exec: GLP-1 Coverage Gaps, China's Supply Chain, and the Clinical Trial Competitiveness Problem
4 months ago
by
Mike Hollan

1:03
Why U.S. Biotech Regulation is Slow
4 months ago
by
Mike Hollan(+1 more)

1:19
Market Movers Rx: AbbVie Leads Gainers
4 months ago
by
Nicholas Jacobus

0:50
Why Your GLP-1 Strategy Is Failing
4 months ago
by
Mike Hollan(+1 more)

0:46
Why U.S. Manufacturing is Losing Its Competitive Edge
4 months ago
by
Nicholas Jacobus(+1 more)

0:54
Why We Need Better Drugs, Not Just More Drugs
4 months ago
by
Mike Hollan(+1 more)

1:21
Market Watch RX: Gilead Joins Top Gainers
4 months ago
by
Nicholas Jacobus

0:27
The Key to AI Scale-Up
4 months ago
by
Michael Christel(+1 more)

1:14
Market Watch Rx: Zoetis Shares Slid
4 months ago
by
Nicholas Jacobus

0:51
The Billions Invested in Domestic Manufacturing
4 months ago
by
Mike Hollan(+1 more)

0:56
Big FDA & EMA Changes for Rare Disease Therapies
5 months ago
by
Mike Hollan(+1 more)

0:53
The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.
5 months ago
by
Mike Hollan(+1 more)

0:36
Why Employers Are Blocking Obesity Drugs?
5 months ago
by
Nicholas Jacobus(+1 more)

1:04
How Novavax’s Protein-Based Vaccine Technology Works
5 months ago
by
Mike Hollan(+1 more)

1:18
Market Watch Rx: Medtronic Leads Gainers
5 months ago
by
Nicholas Jacobus

0:47
Tackling Duplicate Discounts
5 months ago
by
Michael Christel(+1 more)
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Breaks Ground on $3.5 billion Pennsylvania Manufacturing Site
2
Moderna Lays Out Oncology-Driven Growth Plan at 2026 Analyst Day
3
FDA Pauses Commissioner’s National Priority Voucher Program: Report
4
Pfizer and Blackstone Sign Co-Funding Deal for berobenatide
5
